Literature DB >> 2481151

Immunohistochemical spectrum of malignant melanoma. The common presence of keratins.

M Miettinen1, K Franssila.   

Abstract

Acetone-fixed frozen sections of 15 malignant melanomas of the skin with metastases were studied immunohistochemically for the presence of different types of intermediate filament proteins, synaptophysin, muscle cell actins, and desmoplakins. One of the melanomas was a primary toe tumor, and the others mainly regional lymph node metastases. The original diagnosis of melanoma was reconfirmed in each case, and the melanoma diagnosis of the metastases was verified by S100 protein immunostaining in all cases and by a monoclonal antibody to melanoma cells (NK1C3) in 7 cases. All melanomas were prominently vimentin-positive. In 10 of 15 cases, immunoreactive keratin could be demonstrated with antibody CAM 5.2. The presence of keratins was confirmed in selected cases with three other monoclonal antibodies including AE1, PKK1, and a monoclonal antibody specific for keratin number 18. Desmoplakin, another marker of epithelial differentiation, was not found in melanoma cells. Two melanomas contained neurofilament-positive tumor cells, which were however negative for synaptophysin. Desmin, muscle actins, and glial fibrillary acidic protein were not found in the neoplastic cells. On the basis of the present results one could conclude that the protein composition of the cytoskeleton of melanomas is more complex than has been previously thought and most importantly that melanomas may contain keratins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481151

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  17 in total

1.  Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction.

Authors:  S T Traweek; J Liu; H Battifora
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

Review 2.  Role of intermediate filaments in migration, invasion and metastasis.

Authors:  M J Hendrix; E A Seftor; Y W Chu; K T Trevor; R E Seftor
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

Review 3.  Intermediate filaments.

Authors:  M J Hendrix
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

4.  Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors.

Authors:  Jerzy Lasota; Artur Kowalik; Anna Felisiak-Golabek; Sebastian Zięba; Piotr Waloszczyk; Marek Masiuk; Jaroslaw Wejman; Justyna Szumilo; Markku Miettinen
Journal:  Mod Pathol       Date:  2019-02-13       Impact factor: 7.842

5.  Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility.

Authors:  Y W Chu; E A Seftor; L H Romer; M J Hendrix
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

6.  Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.

Authors:  Ryan C Romano; Jodi M Carter; Andrew L Folpe
Journal:  Mod Pathol       Date:  2015-05-29       Impact factor: 7.842

7.  Expression of complete keratin filaments in mouse L cells augments cell migration and invasion.

Authors:  Y W Chu; R B Runyan; R G Oshima; M J Hendrix
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway.

Authors:  R Pankov; A Umezawa; R Maki; C J Der; C A Hauser; R G Oshima
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

9.  An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma.

Authors:  U Fuchs; T Kivelä; P Summanen; I Immonen; A Tarkkanen
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

10.  Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness.

Authors:  Natasa Obermajer; Bojan Doljak; Janko Kos
Journal:  Mol Cancer       Date:  2009-10-21       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.